Ability Biologics

About Ability Biologics

Ability Biotherapeutics is a premier biotherapeutic targeting company dedicated to developing innovative, targeted, immune-modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases. Their mission is to revolutionize targeted therapeutics using their proprietary AbiLeap™ discovery engine to create highly specific and selective antibodies, aiming to transform patient outcomes and redefine industry standards.

Products & Services

AbiLeap™ Discovery Engine:A platform that uses generative AI and a large database of antigen-antibody interactions to create fully human, logic-gated antibody therapeutics with high specificity for immune modulation.

Biotherapeutic Candidates:Four preclinical antibody candidates targeting immuno-oncology, solid tumors, and autoimmune diseases, including Leap 1121 (Autoimmune), Leap 1009 (IO/Solid Tumors), Leap 1030 (IO/Solid Tumors), and an undisclosed candidate (Autoimmune & IO).

Specialties

Logic-gated biotherapeutics Generative AI in antibody discovery Immune modulation Immuno-oncology Autoimmune disease treatments Targeted therapeutics for cancer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 18000000 MR: - FA: US $18 Million FAN: 18000000	D: 2024-06-18 FD: 2024-06-18	6 investors

Seed Latest

2024-06-18

$18.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Elizabeth Quackenbush

Chief Medical Officer

LinkedIn (Pro only)

G

Giles Day

Chief Executive Officer

LinkedIn (Pro only)

J

Jean-Philippe Bürckert

Chief Technology Officer

LinkedIn (Pro only)

P

Patrick Tremblay

Chief Operating Officer

P

Patricia Giblin

Chief Science Officer

M

Matthew Clark

Vice-President Data Sciences

View 10 more team members with Pro

Unlock Full Team Directory

Recent News